The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index, and 1 are not checked yet.
Usage of mobile health interventions among overweight/obese PCOS patients undergoing assisted reproductive technology treatment during the COVID-19 pandemic
Abstract
Objective: In the context of the coronavirus disease 2019 (COVID-19) pandemic, telemedicine is a promising tool for providing clinical care for patients. Since the first-line treatment for infertile women with polycystic ovarian syndrome (PCOS) is lifestyle modification, a mobile-based service that provides lifestyle modification education would be helpful in the treatment of PCOS patients. In this observational study, the effect of a mobile Health (mHealth) application for lifestyle modification on PCOS patients undergoing assisted reproductive technology (ART) treatment was evaluated.Methods: A total of 79 overweight/obese patients (40 in the paper group and 39 in the WeChat application group) with PCOS from the First Affiliated Hospital of University of Science and Technology of China were enrolled in the study. The changes in the outcomes of BMI and ART treatment were analyzed between the two groups.Results: After three months of intervention, the BMIs in the control and mHealth groups were 24.5 ± 3.3 and 23.7 ± 3.1, respectively. The percentage of patients who lost weight was higher in the WeChat group than in the control group (87.2% vs. 67.5%). Furthermore, PCOS patients in the WeChat group were found to have a higher live birth rate than those in the control group (p = 0.005).Conclusion: Lifestyle modifications for PCOS patients undergoing ART treatment using the WeChat application improved weight loss and oocyte quality. Infertile patients with PCOS were more likely to make lifestyle modifications based on the usage of mobile applications during the COVID-19 pandemic.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Most of the included studies (n = 6) were published in 2023 [68,69,71,72,73,74], and two were published in 2022 [70,75].”
From Polycystic Ovary Syndrome and the Internet of Things: A Scoping Review (2024) · cites this paper as [75]
In the citing paper
“For those with PCOS undergoing assisted reproductive technology treatment, the advice through WeChat helped them improve their self-management skills, especially weight-controlling behaviors, and enhance oocyte quality [75].”
From Polycystic Ovary Syndrome and the Internet of Things: A Scoping Review (2024) · cites this paper as [75]
In the citing paper
“Two studies from China used WeChat to provide lifestyle advice [74,75].”
From Polycystic Ovary Syndrome and the Internet of Things: A Scoping Review (2024) · cites this paper as [75]
In the citing paper
“Ten studies included information regarding the use of social media [40,41,68,69,70,71,72,73,74,75]. Two other studies that mention social media were described in the overall context of mobile apps [60] and machine learning [76] (Supplementary File S3).”
From Polycystic Ovary Syndrome and the Internet of Things: A Scoping Review (2024) · cites this paper as [75]
Citations
Cites
(2004) · The Lancet · doi:10.1016/s0140-6736(03)15268-3 · Cited by 12,717
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Fauser, B. C. J. M., Tarlatzis, B. C., Rebar, R. W., Legro, R. S., Balen, A. H., Lobo, R., Carmina, E., Chang, J., Yildiz, B. O., Laven, J. S. E., et al. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.09.024 · Cited by 1,976 · cited 1×
“Previous studies pointed out that overweight/obesity is closely related to PCOS [8,9], affecting half of the patients with PCOS [10].”
BackgroundDigital Technology-Based Telemedicine for the COVID-19 Pandemic
Shen, Y., Liang, C., Yue, W., & Xu, H. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.646506 · Cited by 191
Niu, Z., Lin, N., Gu, R., Sun, Y., & Feng, Y. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3942 · Cited by 140
Systemic and ovarian inflammation in women with polycystic ovary syndrome
Zhai, Y., & Pang, Y. (2022) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2022.103628 · Cited by 140
Chaudhary, H., Patel, J. K., Jain, N. K., & Joshi, R. G. (2021) · Journal of Ovarian Research · doi:10.1186/s13048-021-00879-w · Cited by 121
Duică, F., Dănilă, C. A., Boboc, A. E., Antoniadis, P., Condrat, C. E., Onciul, S., Suciu, N., Creţoiu, S. M., Varlas, V. N., & Crețoiu, D. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.614679 · Cited by 114
Lim, S., Smith, C. A., Costello, M. F., MacMillan, F., Moran, L., & Ee, C. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0434-8 · Cited by 105
Liu, Q., Li, Y., Feng, Y., Liu, C., Ma, J., Li, Y., Xiang, H., Ji, Y., Cao, Y., Tong, X., et al. (2016) · Scientific Reports · doi:10.1038/srep39638 · Cited by 88
Research works printed but not linked: 1
- Aladashvili-Chikvaidze N, Kristesashvili J, Gegechkori M. Types of reproductive disorders in underweight and overweight young females and correlations of respective hormonal changes with BMI. Iran J Reprod Med. 2015;13(3):135–140.
Cited by
COVID-19 and metabolic syndrome
Dissanayake, H. A. (2023) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2023.101753 · Cited by 37
Polycystic Ovary Syndrome and the Internet of Things: A Scoping Review
Graca, S., Alloh, F., Lagojda, L., Dallaway, A., Kyrou, I., Randeva, H. S., & Kite, C. (2024) · Healthcare · doi:10.3390/healthcare12161671 · Cited by 14
Riemma, G., Carotenuto, R. M., Casolari, C., Ronsini, C., Corte, L. D., Verde, M. L., Unfer, V., FRANCISCIS, P. D., Laganà, A. S., & Etrusco, A. (2025) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.70007 · Cited by 14
Wright, P. J., Burts, C., Harmon, C., & Corbett, C. F. (2025) · JMIR Infodemiology · doi:10.2196/68469 · Cited by 8
“Women with PCOS report the expectation of an easily accessible and user-friendly platform [23,25,27,28].”
Wang, Y., Zhao, X., Wang, Y., & Pu, Y. (2024) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2024.12.053 · Cited by 6
Metadata
- Authors
- Sang, M., Wu, Q., Tao, Y., Huang, F., Lu, L., Zhou, W., Li, A., & Bai, S.
- Affiliations
- University of Science and Technology of China (CN)
- Nanjing Jiangning Hospital (CN)
- Corresponding author
- Sang, Meiying
- Bai, Shun
- Venue
- Gynecological Endocrinology
- Publisher
- Informa UK Limited
- Published
- 2022-08-21
- Volume
- 38
- Issue
- 9
- Pages
- 776-780
- ISSN
- 0951-3590 (ISSN-L)
- 1473-0766
- OpenAlex
- W4292560484
- Cited by
- 8
- References
- 31
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 1
- FWCI
- 1.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Gynecological Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
- Keywords
- polycystic ovary syndrome, mobile health, lifestyle modification, assisted reproduction, overweight and obesity, weight loss, live birth rate, infertility, telemedicine, COVID-19 pandemic
- MeSH terms
- COVID-19, Female, Humans, Infertility, Female, Obesity, Polycystic Ovary Syndrome, Telemedicine, Reproductive Techniques, Assisted, Overweight, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Usage of mobile health interventions among overweight/obese PCOS patients undergoing assisted reproductive technology treatment during the COVID-19 pandemic. https://app.cochat.ai/papers/10.1080/09513590.2022.2112170
- The paper
- Sang, M., Wu, Q., Tao, Y., Huang, F., Lu, L., Zhou, W., Li, A., & Bai, S. (2022). Usage of mobile health interventions among overweight/obese PCOS patients undergoing assisted reproductive technology treatment during the COVID-19 pandemic. Gynecological Endocrinology. https://doi.org/10.1080/09513590.2022.2112170
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.